Cancer Research · 2009 · 46 citations · 45 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntigen RecognitionAntitumor T Cell ResponsesCancer ImmunotherapyCancer VaccinesCell-mediated ImmunityTumor-associated AntigensAntigen-specific T Cell ResponsesCd4 Positive T Cell ResponsesCd4 Positive T CellsCd4 T Cell ActivationCd4+ T Helper Cell ResponsesHla-restricted T Cell RecognitionPeptide VaccinationTumor-associated Antigen Recognition
We have previously shown that vaccination of HLA-A2 metastatic melanoma patients with the analogue Melan-A(26-35(A27L)) peptide emulsified in a mineral oil induces ex vivo detectable specific CD8 T cells. These are further enhanced when a TLR9 agonist is codelivered in the same vaccine formulation. Interestingly, the same peptide can be efficiently recognized by HLA-DQ6-restricted CD4 T cells. We used HLA-DQ6 multimers to assess the specific CD4 T-cell response in both healthy individuals and melanoma patients. We report that the majority of melanoma patients carry high frequencies of naturally circulating HLA-DQ6-restricted Melan-A-specific CD4 T cells, a high proportion of which express FOXP3 and proliferate poorly in response to the cognate peptide. Upon vaccination, the relative frequency of multimer+ CD4 T cells did not change significantly. In contrast, we found a marked shift to FOXP3-negative CD4 T cells, accompanied by robust CD4 T-cell proliferation upon in vitro stimulation with cognate peptide. A concomitant reduction in TCR diversity was also observed. This is the first report on direct ex vivo identification of antigen-specific FOXP3+ T cells by multimer labeling in cancer patients and on the direct assessment of the impact of peptide vaccination on immunoregulatory T cells.
45
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
Pierre van der Bruggen, Catia Traversari, Patrick Chomez et al. · Science · 1991 · 3.5K citations
Life Sciences, Immunology, Oncology +17
Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Helen Y. Wang, Dean A. Lee, Guangyong Peng et al. · Immunity · 2004 · 515 citations · Full text
Life Sciences, Immunology, Oncology +12
Pedro Romero, P. Rod Dunbar, Danila Valmori et al. · The Journal of Experimental Medicine · 1998 · 515 citations · Full text
Life Sciences, Immunology, Oncology +17